During the past decade, Hendrick Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hendrick Cancer Center" #1 sponsor was "Celgene" with 1 trials, followed by "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Monopar Therapeutics" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hendrick Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hendrick Cancer Center" are "Breast Cancer" (2 trials), "Chemoradiotherapy-Induced Severe Oral Mucositis" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Hendrick Cancer Center" in a lesser frequency.

Most popular intervention types in "Hendrick Cancer Center" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Clonidine HCl Mucoadhesive Buccal Tablet" (1 trials), "Paclitaxel" (1 trials) and "Pemetrexed Disodium Heptahydrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hendrick Cancer Center" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hendrick Cancer Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hendrick Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hendrick Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".